Apontis Pharma AG Working Capital to Net Assets Ratio
Apontis Pharma AG working capital to net assets ratio. Apontis Pharma AG (APPH) has a Working Capital to Net Assets ratio of 56.7% as of June 2025. Working capital of €17.93 Million (current assets of €21.01 Million minus current liabilities of €3.08 Million) is measured against net assets of €31.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check APPH goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Apontis Pharma AG (2018–2024)
Working capital to net assets ratio of Apontis Pharma AG from 2018 to 2024. This chart shows how Apontis Pharma AG's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 56.7%, reflecting working capital of €17.93 Million against net assets of €31.62 Million EUR. See Apontis Pharma AG defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Apontis Pharma AG Working Capital to Net Assets Ratio by Year (2018–2024)
Apontis Pharma AG working capital to net assets ratio by year from 2018 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Apontis Pharma AG (APPH) total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.2% | €18.69 Million | €31.02 Million | €23.44 Million | €4.75 Million | ▼ -20.8 pp |
| 2023 | 81.0% | €24.52 Million | €30.26 Million | €35.63 Million | €11.11 Million | ▼ -7.8 pp |
| 2022 | 88.8% | €36.90 Million | €41.57 Million | €42.86 Million | €5.96 Million | ▲ +1.8 pp |
| 2021 | 86.9% | €35.39 Million | €40.71 Million | €38.46 Million | €3.07 Million | ▲ +226.7 pp |
| 2020 | -139.8% | €-4.84 Million | €3.46 Million | €13.49 Million | €18.32 Million | ▼ -75.7 pp |
| 2019 | -64.1% | €-2.98 Million | €4.64 Million | €13.86 Million | €16.83 Million | ▼ -79.6 pp |
| 2018 | 15.4% | €1.08 Million | €7.03 Million | €19.06 Million | €17.98 Million | — |